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ABSTRACT
Introduction: Altered biomechanics, increased joint
loading and tissue damage, might be related in a
vicious cycle within the development of knee
osteoarthritis (KOA). We have defined biomechanical
factors as joint-related factors that interact with the
forces, moments and kinematics in and around a
synovial joint. Although a number of studies and
systematic reviews have been performed to assess the
association of various factors with the development of
KOA, a comprehensive overview focusing on
biomechanical factors that are associated with the
development of KOA is not available. The aim of this
review is (1) to identify biomechanical factors that are
associated with (the development of ) KOA and (2) to
identify the impact of other relevant risk factors on this
association.
Methods and analysis: Cohort, cross-sectional and
case–control studies investigating the association of a
biomechanical factor with (the development of ) KOA
will be included. MEDLINE, EMBASE, CINAHL and
SPORTDiscus will be searched from their inception
until August 2015. 2 reviewers will independently
screen articles obtained by the search for eligibility,
extract data and score risk of bias. Quality of evidence
will be evaluated. Meta-analysis using random effects
model will be applied in each of the biomechanical
factors, if possible.
Ethics and dissemination: This systematic review
and meta-analysis does not require ethical approval.
The results of this systematic review and meta-analysis
will be disseminated through publications in peer-
reviewed journals and presentations at (inter)national
conferences.
Trial registration number: CRD42015025092.
INTRODUCTION
The aetiology of osteoarthritis is known to be
both biological and mechanical.1 Although
the sequence is unknown, increased joint
loading and altered biomechanics might
lead to tissue damage. This might deteriorate
into structural changes, potentially with
symptoms of osteoarthritis such as pain and
activity limitations. In turn, structural
changes might lead to further altered bio-
mechanics, forming a vicious cycle.
A recent systematic review showed that
several other risk factors, such as age,
gender, body mass index (BMI) and previous
knee injury, were associated with the develop-
ment of knee pain or knee osteoarthritis
(KOA), in those aged 50 years and over.2 In
an editorial accompanying this review,
Zhang3 suggested that a systematic review
and meta-analysis in biomechanical risk
factors should also be performed. We have
deﬁned biomechanical factors as
joint-related factors that interact with the
forces, moments and kinematics in and
around the knee joint. Current research into
biomechanical factors focuses on four main
biomechanical impairments relevant to tibio-
femoral KOA, that is, skeletal malalignment,
impaired proprioception, muscle dysfunction
and laxity (table 1). Skeletal malalignment
refers to abnormal alignment of or deformity
within the knee joint. Valgus and varus mala-
lignment might lead to increased loads in
the lateral and medial compartment of the
Strengths and limitations of this study
▪ To the best of our knowledge, performing this
review will result in the first article giving an
overview of the existing evidence of biomechan-
ical factors that are associated with the develop-
ment of knee osteoarthritis (KOA).
▪ This review does not assess the mechanism of
how the biomechanical factors are related to the
development of KOA.
▪ This is a protocol article. Results of the system-
atic review and meta-analysis will be published
in a different article.
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tibiofemoral joint, respectively, and thus a possible
increased risk for the development of KOA. Impaired
proprioception refers to a deterioration of the senses of
knee joint position and movement, or a primary neuro-
logical defect. This might lead to more excessive move-
ments, decreased stabilisation during stance and
decreased coordination of complex movement systems
and precise knee joint motions. Deterioration of those
three functions of knee proprioception might lead to
increased joint loading and structural changes.4 Muscle
dysfunction refers to a loss of muscle strength, or muscle
weakness, to loss of muscle endurance, and to changed
muscle activation patterns for the muscles that act on the
knee joint. It is suggested that the knee extensors protect
the joint during loading and movement, by absorbing
shocks and stabilising the knee.5 On the contrary, higher
strength could also lead to higher loads in the knee joint
because of joint space narrowing induced by muscle
strength. Laxity refers to a loss of passive joint stabilisation
due to the inability of passive structures in and around
the knee (knee ligaments, cruciate ligaments and
capsule) to provide an adequate counterbalance to the
mechanical forces acting on the knee during activity. For
example, lateral laxity allows the lateral femoral condyle
to ‘lift of’ the tibial plateau, which increases the medial
joint loading.6 Laxity may adversely affect other biomech-
anical factors.7 Alteration in these four biomechanical
impairments will impact on the loading of the knee.
Abnormal loading is associated with imbalances that may
eventually lead to KOA.8 Within the development of
KOA, biomechanical factors and other risk factors will
interact with each other. For example, gender is asso-
ciated with malalignment, and previous knee injury has
been shown to increase laxity. Although it is not possible
to reduce the risk to develop KOA based on other risk
factors, it might be possible to reduce the additional risk
of the biomechanical factors by preventive strategies (eg,
knee braces, insoles or physical therapy).
The relationship between biomechanical factors and
the development of KOA has been indicated in several
biomechanical studies and systematic reviews, but there is
no systematic review available that contains an overview of
all available evidence of the inﬂuence of particularly bio-
mechanical factors on the development of KOA.5 9–11
Although each biomechancial factor will be assessed with
several different methods, and most studies most prob-
ably have a cross-sectional study design, we expect to be
able to give an overview of biomechancial factors that are
associated with (the development of) KOA. Such an over-
view may be used to identify persons at high risk of devel-
oping KOA. Several strategies like physical therapy, knee
braces or insoles might prevent the development of KOA
in those persons by interacting on the biomechanical
factors. In addition, an overview provides information
that can be used to base the rationale behind strategies to
prevent the development of KOA on and to identify the
focus of future biomechanical and clinical studies.
Objectives
The aim of this review is (1) to identify biomechanical
factors that are associated with (the development of)
KOA and (2) to identify the impact of other relevant
risk factors on this association. Therefore, the proposed
systematic review will answer the following questions:
1. Which are the biomechanical factors that are asso-
ciated with (the development of) KOA?
2. Is the association of these biomechanical factors with
(the development of) KOA mediated by other risk
factors for KOA (ie, high BMI, female gender, history
of previous knee injury and higher age)?
Table 1 Biomechanical impairments and risk factors relevant to the development of KOA, subdivision, and measurement
Impairment/risk factor Subdivision Measurement
Abnormal loading Moments, KRF, KCF, thrust
Skeletal malalignment Leg alignment (eg, HKA), Q-angle
Muscular dysfunction Muscular Strength, HQ-ratio
Neurological Activation pattern, RFD, cocontraction,
coactivation
Impaired proprioception Joint position sense Error, accuracy
Joint movement sense Threshold
Laxity Anterior-posterior Joint line opening with stress
Varus–valgus Joint line opening with stress
High BMI Categorical* Eg, obese, BMI>30
Continuous BMI
Gender Categorical* Male, female
Previous knee injury† Categorical* Eg, ligament rupture, meniscal lesion,
tibia plateau fracture
Age Categorical* Eg, middle-aged, elderly
Continuous Age
*Comparable categorical risk factors will be grouped in analyses, based on decision by the two reviewers.
†Studies should not be influenced by rehabilitation or surgical treatment.
BMI, body mass index; HKA, hip-knee-ankle-angle; H/Q ratio, Hamstrings/Quadriceps ratio; KCF, knee contact force; KOA, knee
osteoarthritis; KRF, knee reaction force; RFD, rate of force development.
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METHODS AND ANALYSIS
This review protocol is registered with the International
Prospective Register of Systematic Reviews at the National
Institute for Health Research and Center for Reviews and
Dissemination (CRD) at the University of York (registra-
tion number: CRD42015025092).12 This systematic review
is reported following the Preferred Reporting Items for
Systematic Reviews and Meta-analyses Protocols guid-
ance.13 The systematic review will be reported following
the Preferred Reporting Items for Systematic Reviews and
Meta-analyses (PRISMA) guidance.14
Studies will be selected according to the criteria out-
lined below.
Type of studies
Studies will be eligible if they are cohort, cross-sectional
or case–control studies. The cohort studies can either be
prospective or retrospective. All cohort studies should
have a follow-up period of at least 1 year. Studies should
not be inﬂuenced by rehabilitation or surgical treatment.
Type of participants
Included studies will be cohort studies examining parti-
cipants who do not have KOA at baseline but who have
KOA at the follow-up measurement, and participants
who do not have KOA at both baseline and follow-up.
Those two groups will be referred to as ‘developing
KOA’ and ‘not developing KOA’. Other included studies
will be case–control and cross-sectional studies that
include both participants with KOA and healthy con-
trols. Participants have KOA if one of the criteria
described in table 2, or an outcome measure related to
the criteria, is fulﬁlled. Both idiopathic and secondary
KOA are eligible. Participants can have osteoarthritis in
one or both knees, although data should be analysed for
only one knee, in order to examine independent asso-
ciations with KOA. Studies examining participants with
both osteoarthritis of the hip and the knee will only be
included if separate data of participants with KOA is
available. Studies examining participants already having
KOA at baseline (cohort studies) or studies examining
‘healthy’ controls having KOA in either the index or the
contralateral knee (cross-sectional or case–control
studies) according to aforementioned criteria will be
excluded. Studies examining participants with osteoarth-
ritis in the patellofemoral joint only will be excluded.
Data regarding patellofemoral osteoarthritis will not be
used, and we will exclude data of individuals stated to
have a combination of patellofemoral and tibiofemoral
osteoarthritis. Cohort studies examining incidence of
KOA in other populations (eg, rheumatoid arthritis and
hypermobility) will be included, although only data
regarding KOA will be used.
Type of biomechanical factors
Studies exploring the association of a biomechanical
factor with (the development of) KOA will be reviewed.
The biomechanical factors will be grouped into one
group referring to abnormal loading, and four main bio-
mechanical impairments relevant to KOA (see table 1).
Table 1 also describes frequently used ways to measure
biomechanical factors. The possible inclusion of mea-
surements of biomechanical factors not listed in table 1
will be discussed by the reviewers ( JT and ADI). Only
biomechanical factors directly related to the knee joint
will be taken into account. Joint angles during activities
will be excluded due to limited reliability of these mea-
surements. Measurements of moments, knee reaction
forces and knee contact forces will be included as mea-
surements of abnormal loading, in contrast with mea-
surements of ground reaction forces and centre of
pressure, because only the ﬁrst gives a comprehensive
estimate of the loading of the knee. The inﬂuence of
other risk factors on the association of biomechanical
factors with (the development of) KOA will also be
reviewed. Studies that only explore non-biomechanical
risk factors will be excluded from this review.
Types of outcome measure
KOA in included studies can be deﬁned by clinical,
radiological, MRI or surgical criteria (see table 2).
Publication year and language
There will be no restriction on publication year and
language.
Table 2 Criteria of osteoarthritis, and hierarchy of
definitions (ranking: A (high)—J (low))
A Clinical KOA According to clinical ACR criteria
B Radiological
KOA
Kellgren and Lawrence grade≥2, or
grade≥2/osteophytes, or Ahlback
grade≥1
C Radiological
KOA
OARSI atlas criteria: sum of
osteophytes or JSN≥grade 2, or
grade 1 JSN in combination with
grade 1 osteophyte
D Clinical KOA Knee pain and≥50 years
E Radiological
KOA
Radiographic signs*; only if the
authors report the participants to
have KOA
F Surgery due to
KOA†
Arthroscopy used to describe KOA
G Surgery due to
KOA†
Osteotomy due to KOA
H Surgery due to
KOA†
Total knee replacement due to KOA
I KOA defined by
MRI
KOA signs on MRI; only if the
authors report the participants to
have KOA
J Clinical KOA Participants report to have KOA
diagnosed by physician
*Eg, osteophytes, cartilage damage, joint space narrowing, bone
marrow oedema.
†Only as outcome measure of cohort study.
ACR, American College of Rheumatology; JSN, joint space
narrowing; KOA, knee osteoarthritis; OARSI, Osteoarthritis
Research Society International.
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Sources and search strategy
The following databases will be searched from their
inception until August 2015: MEDLINE via Pubmed,
EMBASE via OVID, CINAHL (including preCINAHL)
via EBSCO and SPORTDiscus via EBSCO. Reference lists
from included studies and identiﬁed relevant reviews,
textbooks and clinical guidelines will be searched for
relevant references. A citation search will be performed
on highly relevant studies. Experts in the ﬁeld will be
asked for relevant references to ensure literature
saturation.
Literature search strategies will be developed using
medical subject headings (MeSH) and text words related
to osteoarthritis, biomechanical factors and study types.
Search terms from other relevant reviews will be identi-
ﬁed and will be complemented with additional terms for
biomechanical factors. The MEDLINE search strategy is
included in online supplementary appendix 1, and will
be adjusted in order to apply it to other databases.
Study inclusion and exclusion criteria
The inclusion criteria will be:
▸ The study assesses the association of a biomechanical
factor with the development of KOA, and possibly the
impact of other risk factors on this association.
▸ KOA is deﬁned as tibiofemoral osteoarthritis, either
idiopathic or secondary.
▸ A biomechanical factor is a knee joint-related factor
that interacts with the forces, moments and kine-
matics in and around the knee joint.
▸ The study is a cohort study:
– Participants who do not have KOA at baseline but
who have KOA at the follow-up measurement, and
participants who do not have KOA at both baseline
and follow-up.
or
▸ The study is a case–control study or a cross-sectional
study:
– Participants with and without KOA.
The exclusion criteria will be:
▸ The study includes only participants with patellofe-
moral osteoarthritis.
▸ The study does not distinguish between hip osteoarth-
ritis and KOA.
▸ The study is inﬂuenced by rehabilitation or surgical
treatment.
Data management
References from all searches will be uploaded into
EndNote (X7) bibliographic software (Thompson
Reuters, Philadelphia, Pennsylvania, USA). Duplicates
will be removed with the Systematic Review
Assistant-Deduplication Module.15 The remaining dupli-
cates will be removed with EndNote duplicate removal,
and manually by screening for duplicates, while the list
of references will be sorted alphabetically based on
author. All full text ﬁles will be stored in EndNote. For
all studies reviewed in full text, a form regarding
eligibility criteria check will be stored. Data from
included studies will be entered into a data extraction
form in Microsoft Excel. If a meta-analysis is eligible, the
data will be transferred to STATA software (V13.0 or
later, StataCorp LP) to do statistical analysis.
Selection process
Two members of the study team ( JT and ADI) will inde-
pendently screen titles and abstracts of the studies
obtained by the search strategy. The full text of any
study will be obtained if it was judged eligible by at least
one of the reviewers. Then, the two reviewers will use a
standardised form to select studies eligible for inclusion
in the review. Consensus on inclusion will be reached by
discussion. Reasons for excluding studies based on the
full text will be recorded. When more than one study is
based on the same population and contains the same
information with respect to the association at issue, only
one study will be included. This will be based on the fol-
lowing order: (1) the publication with the largest sample
size, (2) the most recent publication or (3) the study
that examined KOA using the highest ranked outcome
measure. Hierarchy of the deﬁnitions is described later
at ‘Data items, outcomes and hierarchy’, and in table 2.
If studies of the same study population present different
information with respect to the association at issue, both
studies will be included. A PRISMA ﬂowchart will be
completed to summarise the process. Neither of the
review authors will be blinded to the journal titles, the
study authors or the institutions.16
Data collection process
Two reviewers ( JT and ADI) will independently extract
data from the included studies using a customised form,
piloted prior to use. Consensus on extracted data will be
reached by discussion, and conﬂictive data extraction
will be discussed with a third member of the study team
(CJ or HL).
Data items, outcomes and hierarchy
Data items that will be extracted from included studies
are described in table 3. Table 3 shows that in cohort
studies, preferably the number of participants develop-
ing KOA and not developing KOA, and the number of
participants exposed and not exposed to the biomech-
anical factor will be extracted. In cross-sectional or case–
control studies, preferably the number of participants
with and without KOA, and the number of participants
exposed and not exposed to the biomechanical factor
will be extracted. If this is not available, mean values for
the biomechanical factors or ORs will be extracted,
respectively. The same data extraction and analyses will be
performed for biomechanical factors and other risk
factors. Therefore, in the following paragraphs only bio-
mechanical factors will be mentioned. The hierarchy for
deﬁnitions of KOA is based on comprehensiveness of the
deﬁnition and the use in clinical practise (see table 2,
ranking: A–J). Symptomatic KOA is based on the
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American College of Rheumatology criteria.17
Radiographic KOA is based on radiological atlases (eg, the
Kellgren and Lawrence (K/L) Classiﬁcation).18 19
In addition, physicians or authors can state that partici-
pants have KOA. The hierarchy will be used for study selec-
tion if more than one study examines the same
population, and for data extraction in studies using two or
more outcome measures of KOA. For the latter, only data
regarding the highest ranked outcome measure will be
extracted.
Risk of bias in individual studies
Risk of bias for each included study will be scored inde-
pendently by two reviewers ( JT and ADI). Consensus on
conﬂicting scores will be reached by discussion. The
Quality In Prognostic Studies tool will be used.20 Six
areas of potential study biases will be assessed: study par-
ticipation, study attrition, prognostic factor measure-
ment, study confounding, outcome measurement and
statistical analysis and reporting. Risk of bias for study
participation is the likelihood that the relationship
between the prognostic factor and the outcome is differ-
ent for participants and eligible non-participants. Risk of
bias for study attrition is the likelihood that the relation-
ship between the prognostic factor and the outcome is
different for completing and non-completing partici-
pants. Risk of bias for prognostic factor measurement is
related to differential measurement of the prognostic
factor related to the level of outcome. Risk of bias for
study confounding is the effect of the prognostic factor
being distorted by another factor that is related to the
prognostic factor and outcome. Risk of bias for outcome
measurement is related to differential measurement of
outcome related to the baseline level of the prognostic
factor. Risk of bias for statistical analysis and reporting is
the risk of bias whether the statistical analysis is depend-
ent on KOA status and the exposure to the biomechan-
ical factor or not, and whether the presentation of
results differs between KOA status and exposure. Study
attrition is not applicable for cross-sectional and case–
control studies, thus will only be rated in cohort studies.
Studies will be classiﬁed as being of high quality if all
study biases are assessed to have a low or moderate risk
of bias. Studies with a high risk of bias for at least one
study bias will be deﬁned as low-quality studies. A
summary statement regarding the quality of the
included studies will be reported in the results section.
Assessment of publication bias
It is assumed that biomechanical projects indicating no
association between a biomechanical factor and (the
development of) KOA are likely to not be published.
Therefore, funnel plots will be used to show the OR on
the x-axis against the sample size on the y-axis for each
biomechanical factor.
Data synthesis
Data will be grouped by the category abnormal loading
and the main biomechanical impairments.
Subsequently, data will be grouped per subdivision of
biomechanical impairments as shown in table 1, and per
study design (ie, cohort studies vs a combination of
cross-sectional and case–control studies). Biomechanical
factors studied in more than one study per study design
will be subjected to meta-analyses. Meta-analyses will be
applied on the OR of developing KOA in participants
who are exposed to the biomechanical factor of interest
(cohort studies), or the OR of the biomechanical factor
being present in participants with KOA compared to the
control group (cross-sectional or case–control studies).
Random effects model (Mantel Haenszel method) will
be used, as large clinical heterogeneity is expected due
to the variation in the deﬁnition of KOA and biomech-
anical factors. Metaregression analyses using study-level
Table 3 Data extraction
All studies
First author Age (mean±SD)
Year of publication BMI (mean±SD)
Study design Definition of KOA used
Duration of follow-up* Definition of BF used
Number of participants Definition of RF used†
Gender (% female) Number of participants
developing KOA* or with
KOA‡
Cohort studies
Case–control or
cross-sectional studies
Number of participants
developing KOA—exposed
to BF/RF
Number of participants with
KOA—exposed to BF/RF
Number of participants not
developing KOA—exposed
to BF/RF
Number of controls—
exposed to BF/RF
Number of participants
developing KOA—not
exposed to BF/RF
Number of participants with
KOA—not exposed to BF/
RF
Number of participants not
developing KOA—not
exposed to BF/RF
Number of controls—not
exposed to BF/RF
or
Mean±SD of biomechanical
factor within participants
developing KOA
Mean±SD of biomechanical
factor within participants
with KOA
Mean±SD of biomechanical
factor within participants not
developing KOA
Mean±SD of biomechanical
factor within controls
or
ORs for the association
between BF/RF and the
development of KOA
ORs for the association
between BF/RF and KOA
Preferably the numbers of participants are extracted. If these are
not available, mean values for the biomechanical or risk factor, or
ORs are extracted, respectively.
*For cohort studies.
†If eligible.
‡For case–control and cross-sectional studies.
BF, biomechanical factor; KOA, knee osteoarthritis; RF, risk factor.
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risk factors as covariates in a multivariate regression ana-
lysis can be used to explore the impact of different bio-
mechanical factors.21 The impact of the biomechanical
factors will be assessed by ﬁtting multiple restricted
maximum likelihood-based metaregression models.22 23
A priori, we deﬁned a relevant covariate (biomechanical
or other risk factor) as one that would decrease the
between-study variance (estimated as tau-squared (τ2), as
a consequence of the inclusion in the meta-regression
analysis.24 Meta-regression analysis will also be used to
assess the impact of other risk factors, combinations of
other risk factors, including interactions between risk
factors, on the association of biomechanical factors with
(the development of) KOA. A forest plot will be made
for each biomechanical factor, and for combinations of
biomechanical factors and other risk factors.
Heterogeneity between studies combined in one
meta-analysis will be examined with standard Q-tests,
and will be calculated as the I2 statistics, measuring the
proportion of inconsistency in the summary effect
measure due to between-study heterogeneity.25 26
If any substantial heterogeneity will be identiﬁed
through analysis of χ2 and I2 statistics, subgroup and sen-
sitivity analyses will be performed. These will only be
performed if at least three studies are included in the
meta-analysis. Subgroup analyses will be used to explore
possible sources of heterogeneity. Subgroups will
be based on the outcome deﬁnition used, that is, clin-
ical, radiological, MRI and surgical criteria. Subgroups
will also be identiﬁed based on the ways to measure
the biomechanical factor and the duration of follow-
up (cohort studies). Other subgroups will be tibiofe-
moral osteoarthritis and general KOA, and medial and
lateral tibiofemoral osteoarthritis. Sensitivity analyses will
be carried out based on risk of bias. If sensitivity analyses
appear to inﬂuence the ﬁndings of the review, this will
be reported and discussed in the ‘Discussion’ section.
Confidence in cumulative estimate
The quality of evidence will be evaluated for the associ-
ation of the category abnormal loading, and each sub-
division of a biomechanical impairment with the
(development of) KOA, because this relates to different
assessment strategies for clinicians and healthcare provi-
ders. The Grading of Recommendation, Assessment,
Development and Evaluation framework adapted for
prognostic studies will be used.27 Factors that may
decrease the quality level of evidence are phase of inves-
tigation, study limitations, inconsistency, indirectness,
imprecision and publication bias. Factors that may
increase the quality level of evidence are moderate or
large effect size and exposure-response gradient. It is
proposed to base the starting point for the quality level
of evidence on phase of investigation. This is not applic-
able for cross-sectional and case–control studies.
Therefore, the starting point for these studies will be
low. Quality level of evidence will be determined as high,
moderate, low or very low, and will be reported in the
summary of ﬁndings table. Quality of evidence will also
be assessed for combinations of biomechanical factors
and risk factors that will be examined in meta-analyses.
An algorithm will be developed that can be used by
healthcare providers to identify the biomechanical risk
factors which are present in persons at high risk of devel-
oping KOA.28 Biomechanical factors will be divided into
categories base on study type (longitudinal and cross-
sectional/case–control studies) and base of evidence.
Evidence will be based on a signiﬁcant meta-analysis, a
longitudinal or cross-sectional/case–control study with a
signiﬁcant ﬁnding, an insigniﬁcant meta-analysis, or on
a longitudinal or cross-sectional/case–control study with
insigniﬁcant ﬁndings. This results in different categories
within the algorithm; must consider (signiﬁcant
meta-analysis), maybe consider (study with signiﬁcant
ﬁnding), do not consider (insigniﬁcant meta-analysis),
and not currently clinically relevant (study with insigniﬁ-
cant ﬁndings).
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